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Environmental signals that trigger bacterial pathogenesis and biofilm formation are mediated by changes in the level
of cyclic dimeric guanosine monophosphate (c-di-GMP), a unique eubacterial second messenger. Tight regulation of
cellular c-di-GMP concentration is governed by diguanylate cyclases and phosphodiesterases, which are responsible for
its production and degradation, respectively. Here, we present the crystal structure of the diguanylate cyclase WspR, a
conserved GGDEF domain-containing response regulator in Gram-negative bacteria, bound to c-di-GMP at an
inhibitory site. Biochemical analyses revealed that feedback regulation involves the formation of at least three distinct
oligomeric states. By switching from an active to a product-inhibited dimer via a tetrameric assembly, WspR utilizes a
novel mechanism for modulation of its activity through oligomerization. Moreover, our data suggest that these
enzymes can be activated by phosphodiesterases. Thus, in addition to the canonical pathways via phosphorylation of
the regulatory domains, both product and enzyme concentration contribute to the coordination of c-di-GMP signaling.
A structural comparison reveals resemblance of the oligomeric states to assemblies of GAF domains, widely used
regulatory domains in signaling molecules conserved from archaea to mammals, suggesting a similar mechanism of
regulation.
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Introduction
Bacterial signal transduction pathways regulating virulence
and chemotaxis are commonly composed of two-component
signaling systems. These systems consist of a histidine protein
kinase that relays environmental stimuli to phosphotransfer
reactions, ultimately controlling the activity of phospho-
receiver domain-containing response regulator proteins [1].
These phosphorylation-activated switches have been de-
scribed as undergoing rather simple, reversible changes in
oligomerization state and/or conformation, and are often
presented as modular proteins with a regulatory phospho-
receiver domain being linked to an effector domain [2].
An emerging family of response regulators controls the
cellular level of the bacterially unique second messenger, bis-
(39-59)-cyclic dimeric guanosine monophosphate (cyclic di-
GMP or c-di-GMP) [3–6]. Enzymes responsible for c-di-GMP
synthesis and degradation have been identiﬁed in most
eubacteria, being absent in archaea and eukaryotes [7].
GGDEF and EAL describe the consensus sequence motif in
the active site of these enzymes. Diguanylate cyclases of the
GGDEF family catalyze the cyclization of two guanosine
triphosphate (GTP) molecules to one c-di-GMP molecule
[8,9], and have been shown to be homologous to adenylate
cyclases [10]. Phosphodiesterase (PDE) activity responsible for
the breakdown of c-di-GMP has been demonstrated for EAL
domain-containing proteins of an unknown fold [11–13].
Levels of c-di-GMP trigger cellular responses relevant to
pathogenesis, such as in motility, secretion, cytotoxicity, and
bioﬁlm formation, a differentiation process by which bacteria
switch from a planktonic, single-cell–based suspension to a
sessile community life-form [14]. Bioﬁlms have been associ-
ated with chronic infections, for example of the ear, heart, or
lungs, especially in patients suffering from cystic ﬁbrosis.
Bioﬁlms often induce tolerance or resistance to host defense
and antibiotic treatment [15]. Enhanced bioﬁlm formation
has been attributed to high cellular c-di-GMP concentration,
whereas low levels of c-di-GMP can lead to an impairment of
bioﬁlm formation and cytotoxicity [16–18], suggesting that
cellular c-di-GMP levels, and thus the activity of c-di-GMP–
speciﬁc cyclases and PDEs, are under tight control.
Mechanistic information regarding the modes of regula-
tion of GGDEF and EAL domain-containing proteins is
sparse. Structural models are only available for the diguany-
late cyclase PleD from Caulobacter crescentus [19], consisting of
two CheY-homology phospho-receiver domains and a
GGDEF domain (Figure S3B and S3C). In the structure of
unphosphorylated PleD, the ﬁrst CheY-homology domain
containing the phosphorylation switch is in an inactive
conformation [19]. Cyclic di-GMP is bound to the catalytic
site as well as to a second site distal to the catalytic loop. The
latter is composed of a motif on the GGDEF domain (RxxD
motif) and the second CheY-homology domain. Subsequently,
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PLoS BIOLOGYthe RxxD motif has been shown to be a conserved allosteric
inhibitory site (I-site) in GGDEF domain-containing proteins
[20]. A model for regulation by phosphorylation and
dimerization has been proposed for PleD with c-di-GMP
serving as a noncompetitive inhibitor [21]. A recent crystal
structure of PleD bound to the phosphoryl analog beryllium
ﬂuoride (BeF3
 ) conﬁrms such a mechanism [22]. The
structure also highlights a second mode of product inhibition
in which c-di-GMP bridges two cyclase domains in the
activated dimer.
WspR (PA3702 in Pseudomonas aeruginosa), often described
as an ortholog of PleD, is a conserved response regulator of a
chemosensory signaling system controlling bioﬁlm formation
and other adaptive phenotypic changes in Pseudomonas and
related species [23,24] (Figure S1). Overexpression of WspR
causes hyperbioﬁlm formation, whereas loss-of-function
mutants show reduced bioﬁlm formation and cytotoxicity
[17], suggesting that WspR is a potent switch controlling
virulence mechanisms. WspR has a similar domain organ-
ization as PleD; however, it lacks the second CheY-homology
domain (Figure 1A). As observed with PleD, WspR appears to
be regulated by phosphorylation of the N-terminal CheY-
homology phospho-receiver domain [24]. A recent systematic
mutagenesis study identiﬁed other functionally important
regions in WspR, but the exact mechanism of regulation
remains unknown [25].
Here, we present the crystal structure of WspR from P.
aeruginosa with c-di-GMP bound at its inhibitory site. WspR is
trapped in the crystal in a distinct inactive state that suggests
a novel mechanism of feedback inhibition and activation.
Crystal symmetry–related molecules form a catalytically
inactive tetrameric assembly mediated predominantly by an
antiparallel packing of helical stalks, coiled-coil motifs
connecting the regulatory CheY modules to the GGDEF
domains. Unexpectedly, in solution, the product-inhibited
conformation corresponds to an elongated dimer. Upon c-di-
GMP hydrolysis by PDE treatment, the conformation switches
to a more compact dimer with high activity. We show that the
tetrameric species serves as a scaffold for the formation of the
inhibited, elongated state from the active, more compact
state, and is a required intermediate for establishing c-di-
GMP–mediated inhibition. Hence, the tetrameric assembly
observed in the crystal covers features of both dimeric states.
Although some of the structural hallmarks are similar to the
ones observed for PleD [19,22], we propose a novel,
phosphorylation-independent mode of regulation for WspR,
based on a biochemical characterization of the inhibition
mechanism.
Results/Discussion
Crystal Structure of WspR from P. aeruginosa
We determined the crystal structure of full-length WspR
from P. aeruginosa containing a CheY-homology and GGDEF
domain at 2.4 A ˚ resolution (Figure 1; Table S1). The structure
was solved by molecular replacement using the isolated CheY
(D1) and GGDEF domains of C. crescentus PleD as search
models [19]. Electron density maps, phased by molecular
replacement, are of good quality and reveal novel features
that were built with conﬁdence (Figure S2 and Table S1). The
asymmetric unit contains two molecules with similar con-
formation that only differ by a 168 rigid body rotation with
respect to the relative orientation of the GGDEF domain and
the N-terminal regulatory unit (Figure 1B and 1C).
In the crystal lattice, WspR forms a tetramer by an
antiparallel packing of two WspR dimers (Figure 1B and
1D; ‘‘S’’ or ‘‘SYM’’ in the diagrams indicates crystal
symmetry–related molecules). In these dimers representing
the asymmetric unit, the CheY-homology domains adopt a
conformation reminiscent of an active phospho-receiver
dimer observed in OmpR/PhoB-type response regulators
[26] (Figure S3A). Due to the lack of posttranslational
modiﬁcations (see Material and Methods), and considering
the coordination geometry, extra density near the conserved
aspartates at the active site of the CheY domains was
interpreted as Mg
2þ ions (Figure 1B). The C-terminal helices
of the CheY-homology domains, referred to as stalks, were
clearly resolved in the electron density maps after molecular
replacement, and extend to long coiled-coil–like structures
that connect to the GGDEF domains (Figure S2A). The
GGDEF domains are oriented such that the two active sites
face each other, similar to conformations of active adenylate
cyclases [27] (Figure 1B). In addition, the electron density
maps clearly revealed binding of an intercalated c-di-GMP
dimer to a conserved inhibitory site (I-site) [20] (Figure S2B).
The conformation of the nucleotides and their mode of
interaction with the GGDEF domain are similar both to
small-molecule crystal structures of c-di-GMP and the
conformation seen when bound to PleD [19,22,28,29] (Figure
1B and 1E).
Although the structure of WspR represents a similar
functional state as the c-di-GMP–bound conformations of
PleD and highlights conservation of regulatory features
[19,20], it reveals major structural differences that suggest a
distinct mechanism of product inhibition (Figure S3B and
S3C). In monomeric PleD, c-di-GMP binds both to the I-site
located at the GGDEF domain and the second CheY-
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Author Summary
Bacteria can switch from a single-cell, free-floating behavioral mode
to a community life-form via colonization of surfaces and the
secretion of an extracellular matrix. This process, called biofilm
formation, has been attributed to a majority of chronic infections,
including the lungs, as occurs in patients with cystic fibrosis.
Recently, a small intracellular signaling molecule, the nucleotide
cyclic dimeric guanosine monophosphate (c-di-GMP), and enzymes
for its production and degradation have been discovered that relay
environmental cues to changes in secretion, cell adhesion and
ultimately, biofilm formation and virulence. We have studied the
molecular mechanism and mode of regulation of WspR, an enzyme
from Pseudomonas and related pathogenic bacteria responsible for
the generation of c-di-GMP and biofilm formation. On the basis of its
crystal structure and functional assays, we elucidated a sophisticated
regulatory mechanism in WspR that is controlled by feedback
inhibition mediated by c-di-GMP. We hypothesize that WspR is
primed for the (re)activation by enzymatic degradation of the
inhibitory nucleotide. In addition, we identified mutations at the
inhibitory site of WspR in a subset of bacteria that are frequently
found in cystic fibrosis patients, suggesting that altered c-di-GMP
signaling, mediated by modified WspR, may contribute to the
pathogenicity of these strains. Furthermore, we present a structural
comparison with GAF domains, which are widely used conserved
regulatory signaling domains, suggesting a similar mechanism of
regulation.Figure 1. Structure of WspR from P. aeruginosa
(A) Domain organization of WspR. The N-terminal CheY-homology phospho-receiver domain is connected via a helical stalk to the GGDEF domain with
diguanylate cyclase activity. In WspR, the active site loop contains the GGEEF motif (residues 251–255).
(B) The crystal structure of WspR. The crystals contain two molecules in the asymmetric unit. Two orthogonal views are shown with coloring for
molecule A as shown in (A). Molecule B is colored grey. The GGEEF motif is shown in yellow. Cyclic di-GMP molecules bound to the inhibitory site (I-site)
are located distal to the active site and are shown as sticks. Mg
2þ ions are shown as brown spheres.
(C) Comparison of the two WspR molecules in the asymmetric unit. Molecules A and B were aligned through superpositioning of their GGDEF domains.
The CheY-stalk modules are separated by a rigid body rotation of 168 around residue 172 at the tip of the helical stalk.
(D) Crystallographic tetramer consisting of two symmetry-related dimers representing a biological unit. Two C2-symmetry–related crystallographic
dimers of WspR are shown intertwined in a head-to-head orientation. The stalks form a tetrameric structure splaying apart the coiled-coils and
physically blocking the active sites. Cyclic di-GMP molecules bound at the I-site bridge the GGDEF domains of neighboring molecules. ‘‘S’’ or ‘‘SYM’’ in
the cartoon diagram indicate crystal symmetry-related molecules. The boxed region is shown in (E).
(E) Close-up view of the I-site. In the crystal, two intercalated c-di-GMP molecules are bound at the I-site located at the back of the GGDEF domain distal
to the catalytic site. An arginine side chain (R198) contributed by a symmetry-related GGDEF domain completes the I-site. Asterisks indicate residues
targeted for site-directed mutagenesis.
doi:10.1371/journal.pbio.0060067.g001
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Structure and Regulation of WspRhomology domain (D2) [19]. Whereas the two CheY-homology
domains of PleD (D1-D2; including their protruding terminal
helices) superimpose well with the phospho-receiver dimer of
WspR, their position relative to the GGDEF domains is
markedly different (Figure S3B and S3C). In addition, WspR
lacks the second phospho-receiver domain that is part of the
I-site in PleD, suggesting that c-di-GMP might mediate
product inhibition of WspR by a different mechanism. In
the dimeric state of PleD, activated by BeF3
 , product
inhibition is achieved by I-site–bound c-di-GMP bridging
the GGDEF domains, locking them in an inactive conforma-
tion [22] (Figure S3C). This feature is conserved in the WspR
structure but is part of a vastly different regulatory
mechanism.
Cyclic di-GMP at the I-site is bound to two conserved
arginine residues, R242 and R198, the latter being contrib-
uted by a symmetry-related GGDEF domain (Figure 1E). The
GGDEF dimer conformation and mode of c-di-GMP binding
is similar to that of activated, dimeric PleD [22] with a few key
differences (Figure S3C). The WspR crystal structure exists in
a tetrameric assembly, with helical stalks from a C2-symmetry
mate physically blocking the active sites of the diguanylate
cyclase domains by being splayed apart (Figures 1D). We
presume that the stalks have to extend the coiled-coil region
in a WspR dimer to bring the GGDEF domains into close
proximity for full cyclase activity (arrow in Figure S4A,
center). This is in agreement with the prediction that the
regions spanning residues 140 to 171 form a coiled-coil
structure (Figure S1). Additionally, residues that comprise the
coiled-coil contacts in the active dimer are identical to the
residues involved in the antiparallel oligomerization of the
stalks (Figure S4D–S4F).
Cyclic di-GMP Binding Relies on Intact Active and
Inhibitory Sites
As in the majority of diguanylate cyclases, WspR features a
RxxD motif in the core of the I-site (R242xxD245 of WspR)
spatially close to the active site’s GGEEF motif [20] (Figure
1E). Similar to the structure of activated PleD, a crystal
symmetry–related GGDEF domain complements the I-site of
WspR by contributing a second arginine side chain (R198)
[22]. To corroborate these structural observations, we
investigated the identity of bound nucleotide to puriﬁed
wild-type WspR (WspR
wt; red trace) and mutant proteins. We
used a high-performance liquid chromatography (HPLC)-
based assay providing high-resolution separation and robust
detection of guanosine nucleotides (Figure 2A). For the
analysis, puriﬁed proteins were heat denatured, and ﬁltered
supernatants were subjected to reverse-phase chromatogra-
phy.
Cyclic di-GMP co-puriﬁed with the enzyme upon over-
expression in Escherichia coli (Figure 2A). The intrinsic off-rate
of nucleotide from the I-site was extremely slow with no
signiﬁcant loss of c-di-GMP observed upon dialysis for several
days (unpublished data). To produce a nucleotide-free species
of WspR, we preincubated WspR
wt with an EAL domain–
containing PDE, SadR/RocR from P. aeruginosa. Similar results
were obtained with other c-di-GMP–speciﬁc PDEs, suggesting
that WspR-bound c-di-GMP is readily accessible for catalytic
cleavage (unpublished data). PDE treatment results in the
degradation of c-di-GMP to free pGpG that could be easily
removed by gel ﬁltration (Figure 2A and 2C). We distinguish
between PDE-treated (WspR
wt: PDE-treated; black trace) and
nucleotide-free (WspR
wt: nuc.-free; green trace) WspR
wt. In the
latter case, PDE treatment was part of the puriﬁcation
protocol, but PDE and free nucleotides had been removed.
WspR
wt: nuc.-free puriﬁcation proceeded as described for
WspR
wt and mutant proteins (see Material and Methods).
A catalytically dead mutant in which the two central
glutamate residues of the active site have been replaced by
alanines (WspR
GGAAF; orange trace) puriﬁed nucleotide-free
(Figure 2B), indicating that WspR’s activity was required for
c-di-GMP binding to the I-site in cells. Yet, puriﬁed
WspR
GGAAF was able to bind c-di-GMP when incubated with
free c-di-GMP (unpublished data). Site-directed mutants that
lack either the R242 or R198 side chains at the I-site
(WspR
R242A and WspR
R198A; blue and purple trace, respec-
tively) puriﬁed essentially nucleotide-free but are highly
active enzymes (Figures 2B) (see below), suggesting that c-di-
GMP has low afﬁnity for the active site.
Cyclic di-GMP Stabilizes WspR in an Elongated, Dimeric
Conformation
Degradation of c-di-GMP by PDE treatment has a profound
effect on the elution proﬁle of WspR in size-exclusion
chromatography (SEC) (Figure 2C). Nucleotide-bound
WspR
wt eluted at approximately 12.1 ml. Upon incubation
with PDE (30:1 molar ratio of WspR to PDE), this peak
decreased, and a new peak appeared at an elution volume of
approximately 13.3 ml, with complete conversion after 2 h of
incubation. In the nucleotide-bound enzyme, c-di-GMP
contributes signiﬁcantly to the absorbance at 280 nm. Release
of pGpG, the product of the PDE-catalyzed reaction, led to a
decrease of absorbance across the protein-containing peak in
parallel with the appearance of a nucleotide peak coeluting
with other small molecules and salts (Figure 2C).
A similar analysis was applied to nucleotide-free WspR
wt
and mutants with disrupted active (WspR
GGAAF) or I-site
(WspR
R242A or WspR
R198A) (Figure 2D). Whereas c-di-GMP–
bound WspR
wt eluted as a single peak (peak 2 in Figure 2D),
the nucleotide-free proteins showed a bimodal distribution
with peaks at an elution volume of approximately 11.7 ml
(peak 1 in Figure 2D) and, similar to the PDE-treated sample,
of approximately 13.3 ml (peak 3 in Figure 2D). The relative
distribution was dependent on protein concentration with a
shift to faster eluting proteins at higher concentration (see
below; Figure 5C). The detection of these different species by
gel ﬁltration indicated the existence of distinct conforma-
tions of WspR depending on its nucleotide-bound state.
SEC has the limitation that it is not possible to distinguish
whether an observed shift in elution is due to a conforma-
tional change affecting the shape of the particle (e.g., rod-
shaped versus globular) and/or a change in stoichiometry, an
obstacle for calibration of this method. In order to determine
the absolute molecular weight, and hence assembly state of
WspR in solution, we turned to static multiangle light
scattering (coupled to SEC) [30]. The technique relies on the
fact that the intensity of scattered light produced by a
macromolecule is proportional to its molecular weight.
Sample concentration and time-averaged intensity of scat-
tered light, collected simultaneously at different angles, are
measured as the protein elutes from a gel ﬁltration column.
The measurements are insensitive to the shape of the
molecules and assemblies, yielding the absolute molecular
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the mass distribution in the sample [31]. In addition,
molecular weights can be correlated to the elution time in
SEC.
The results for mutant and wild-type proteins discussed
above are shown in Figure 3 and summarized in Table 1
(including nucleotide binding and activity data). Bovine
serum albumin (BSA) served as an isotropically scattering
sample for the normalization of the light-scattering detectors
(Figure 3A). The averaged molecular weight measured across
the peak corresponding to monomeric BSA (70.4 kDa, with a
polydispersity index of 1.003) is in good agreement with the
theoretical value (66.4 kDa).
To our surprise, both nucleotide-bound and PDE-treated
WspR were essentially dimeric at a concentration of
approximately 4 mg/ml (0.1 mM; initial concentration before
gel ﬁltration) but eluted at distinct positions, as observed with
gel ﬁltration (Figure 3B and 3C; Table 1). Given identical
stoichiometry, both states differ only in their hydrodynamic
radius with the c-di-GMP–bound WspR
wt eluting as an
elongated dimer, whereas PDE-treated WspR appears to be
more globular in shape. Low polydispersity indices and the
absence of tetramers in these samples indicate that dimers
were the predominant species under these conditions and
that conversion from the elongated to compact species might
be direct, not transitioning through a tetrameric state (Table
1). Alternatively, the tetramer might be a very transient
intermediate during the switching between the dimeric states.
A small, but detectable, tetrameric fraction assembled upon
prolonged incubation in the absence of c-di-GMP (see below;
Figure 5C).
In contrast, the nucleotide-free mutants (WspR
GGAAF,
Figure 2. Cyclic di-GMP Binding and Gel Filtration Profile of Wild-Type and Mutant WspR
(A) Detection of guanosine nucleotides by a reverse-phase HPLC-based assay. GTP, GDP, linear di-GMP (pGpG), c-di-GMP, and an intermediate
condensation product (linear GTP-GMP; pppGpG) are well separated in this assay (grey dashed line). Products corresponding to pppGpG and pGpG
were identified by mass spectrometry (unpublished data). Cyclic di-GMP was commercially available. WspR expressed in E. coli purifies with c-di-GMP
bound (red trace) that is accessible for PDEs (black trace).
(B) I-site and active site mutants of WspR purify nucleotide-free. Mutant proteins with disrupted I-sites (WspR
R242A or WspR
R198A; blue and purple traces,
respectively) or catalytic site (WspR
GGAAF; orange trace) were analyzed. Nucleotide-free WspR
wt is obtained by PDE treatment followed by repurification
using affinity and size exclusion columns (green trace).
(C) PDE treatment triggers a conformational change in WspR. Cyclic di-GMP–bound WspR
wt (0.24 mM) was incubated with PDE (0.008 mM) in gel
filtration buffer (25 mM Tris-Cl [pH 7.5], 100 mM NaCl, and 1 mM DTT) supplemented with 10 mM Mn
2þ for 0.5, 1, or 2 h at 25 8C. Reactions were
analyzed by SEC on a Superdex200 10/300 column (GE Heathcare).
(D) SEC profiles of mutant and wild-type WspR. Nucleotide-bound and nucleotide-free WspR
wt (red and green traces, respectively), WspR
GGAAF (orange
trace), WspR
R242A (blue trace), and WspR
R198A (purple trace) (0.24 mM) were analyzed by analytical gel filtration in gel filtration buffer. Peak maxima at
11.7 (peak 1), 12.1 (peak 2), and 13.3 ml (peak 3) are labeled. Peaks 1–3 (Superdex 200 10/30 column; GE Healthcare) correspond to peaks 1–3 (Shodex
KW-803 column; JM Science, Inc.) in Table 1, obtained from the SEC coupled to the static multiangle light-scattering detectors.
doi:10.1371/journal.pbio.0060067.g002
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Structure and Regulation of WspRFigure 3. SEC-Coupled Multiangle Light-Scattering Analysis of Purified WspR in Solution
(A) Monomeric BSA (4 mg/ml; Sigma) was analyzed by coupled SEC/multiangle light scattering. The mobile phase consists of 25 mM Tris-HCl (pH 7.5),
100 mM NaCl, and 1 mM DTT. In the left panel, the primary signal (in volts) is plotted against the elution volume. The solid (colored) trace shows the
signal of one of the light-scattering detectors (at 908 to the incident beam). The signal from the refractive index detector is shown as a dashed line. The
grey area highlights the analyzed peak. The void volume (void) and the end of the experiment (buffer) are indicated. In the right panel, molecular
weights, determined by light scattering, and protein concentration, measured by change of refractive index, from each data slice (0.5-s increments) are
plotted against the elution volume. The grey horizontal line indicates the theoretical molecular weight.
(B–E) Cyclic di-GMP–bound WspR
wt (4 mg/ml) (B), PDE-treated WspR
wt (4 mg/ml) (C), WspR
GGAAF (4 mg/ml) (D), and WspR
R242A (4 mg/ml) (E) were
analyzed as described in (A). The grey horizontal lines indicate the theoretical molecular weight for monomers, dimers, and tetramers.
doi:10.1371/journal.pbio.0060067.g003
PLoS Biology | www.plosbiology.org March 2008 | Volume 6 | Issue 3 | e67 0606
Structure and Regulation of WspRWspR
R242A, or WspR
R198A) partitioned into a compact dimer
and a tetrameric species eluting later and earlier, respec-
tively, than the elongated c-di-GMP–bound WspR
wt dimer
(Figure 3D and 3E; Table 1). Since tetramerization occurred
in the nucleotide-free proteins with disrupted I-site or active
site, higher-order oligomerization is likely to be driven by
interactions of the stalk motifs rather than c-di-GMP.
Elongated and Compact Dimers Exhibit Distinct Catalytic
Activities
To assess whether the different oligomeric species corre-
spond to a certain activity state, we applied both an HPLC-
based and a colorimetric assay. Reaction products from
incubations of nucleotide-free WspR
wt with GTP/Mg
2þ were
analyzed (Figure 4A). In addition to a GTP peak eluting at 3.9
min, the HPLC proﬁle showed two peaks eluting at 10.8 and
14.2 min, respectively. The peak with the longer retention
time corresponds to c-di-GMP based on its coelution with
puriﬁed c-di-GMP (Figures 4A and 2A). Mass spectroscopy
was used to identify the other peak as a product resulting
from a single phosphodiesteriﬁcation of two GTP molecules
to a linear GTP-GMP species (pppGpG). Puriﬁed pppGpG
could serve as a substrate for WspR resulting in the
production of c-di-GMP, suggesting that it is an intermediate
along the reaction coordinates for diguanylate cyclization
(unpublished data). Addition of BeF3
 or acetyl phosphate did
not accelerate the reactions (unpublished data), consistent
with constitutive dimerization of WspR even in the absence of
phosphorylation (Table 1; see Materials and Methods).
For kinetic analysis of wild-type and mutant WspR, we
turned to a coupled enzyme assay that monitors the
production of pyrophosphate, a product of the cyclization
reaction. Whereas WspR
GGAAF was catalytically inactive,
showing no activity above background (buffer control), all
other compact, dimeric species of WspR (nucleotide-free
WspR
R242A,W s p R
R198A,W s p R
wt: nuc.-free,a n dc - d i - G M P –
bound WspR
L170D) were highly active (Figures 4B and S6).
In contrast, the elongated, nucleotide-bound WspR
wt dimer
showed slow kinetics. In light of the model discussed below,
the residual activity most likely originated from a small
fraction of an active species of the protein. Thus, the compact
and the elongated dimeric conformations of WspR corre-
spond to distinct active and inactive states of the enzyme.
The residues involved in oligomerization, c-di-GMP bind-
ing, and production are conserved in WspR from other
Pseudomonas species (Figure S5A). In order to analyze
conservation of the regulatory mechanism, we cloned,
expressed, and puriﬁed WspR from P. putida, ﬂuorescence, and
syringae. The protein sequences are 74%–84% identical to
each other (including P. aeruginosa) (Figure S5B). The results
obtained for these proteins were equivalent to the ones
described above for WspR from P. aeruginosa with regards to
nucleotide binding state, switching mechanism, and activity
(Figure S5C–S5E).
We also analyzed mutant enzymes with aspartate substitu-
tions in the hydrophobic residues critical for coiled-coil
formation and oligomerization (WspR
L170D and WspR
L167D)
(Figure S4D–S4F). Results for oligomerization propensity,
nucleotide-bound state, and activity are summarized in Table
1 and Figure S6. Whereas WspR
L170D existed in a compact
dimer–tetramer equilibrium similar to the one observed for
nucleotide-free forms of WspR, WspR
L167D eluted later, with
a molecular weight measured to be 55.0 kDa, suggesting a
weakly associating dimeric species (Figure S6C and Table 1).
Both WspR
L170D and WspR
L167D puriﬁed with c-di-GMP
bound (Figure S6B), but only WspR
L170D had signiﬁcant
catalytic activity (Figure S6D). WspR
L167D was inactive in the
conditions used. PDE treatment of WspR
L170D and WspR
L167D
had no effect on their catalytic activity (unpublished data),
suggesting that c-di-GMP binding to the I-site is not sufﬁcient
for achieving product inhibition (see below). Taken together,
these results highlight the importance of dimerization driven
by the CheY domains and the protruding coiled-coil motifs
Figure 4. Activity of Distinct WspR Species
(A) HPLC-based activity assay measuring c-di-GMP production by WspR
wt. Nucleotide-free WspR
wt (green trace) or WspR
GGAAF (orange trace) (10 lM)
was incubated in buffer containing GTP/Mg
2þ(1 mM/2 mM) for 1 h at 25 8C. Nucleotides were analyzed by reverse-phase HPLC after heat denaturation
of proteins and ultrafiltration of the supernatants, and reaction products were compared to retention times of well-characterized nucleotide standards
(grey trace and Figure 2A).
(B) Comparison of enzymatic activity of wild-type and mutant forms of WspR. WspR
wt (nucleotide-bound or -free), or mutant variants (0.5 lM) were
incubated at 25 8C in assay buffer (EnzChek Pyrophosphate Assay; Invitrogen) containing GTP/Mg
2þ (0.5 mM/2 mM), and pyrophosphate production
was measured by continuously monitoring absorbance at 360 nm. Coloring corresponds to the scheme in Figure 2. Error bars indicate standard
deviations of three independent experiments. Incubation of inorganic pyrophosphate (PPi; grey trace) (0.5 mM) in assay buffer determines the rate limit
of the assay system. In the buffer control (black trace), GTP/Mg2þ is included in the reaction.
doi:10.1371/journal.pbio.0060067.g004
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Structure and Regulation of WspRfor activity and the importance of the leucine residues in
establishing the autoinhibited state.
Tetramerization Is an Essential Step in Establishing
Feedback Inhibition
To investigate the molecular mechanism for product
inhibition, we reconstituted a reaction cycle starting with
the elongated, c-di-GMP–bound inactive WspR
wt species
(dimer*; red trace; Figure 5A). For each step in the reaction
cycle outlined in Figure 5A, we determined the nucleotide-
bound state, analytical gel ﬁltration proﬁle (providing insight
into molecular weight and shape of the protein), and
diguanylate cyclase activity (Figure 5B–5E).
As observed before, treatment of WspR with PDE produced
pGpG, removing the inhibitor from the I-site (Figure 5B).
This reaction was accompanied by a conformational change
altering the mobility of WspR
wt to a later eluting, more
compact species (sample 1b; WspR
wt: PDE-treated; black trace)
when compared to sample 1, the original elongated dimer
(Figure 5C). PDE and free nucleotide were removed, and
nucleotide-free WspR was subjected to gel ﬁltration, follow-
ing the protocol for the preparation of WspR
wt: nuc.-free (see
above; Material and Methods). Over the course of this
treatment, a small fraction of the tetrameric species, eluting
at 11.7 ml, assembled although the enzyme concentration was
not altered signiﬁcantly (sample 2; WspR
wt: nuc.-free; green
trace) (Figure 5C).
Cyclic di-GMP production was initiated by the addition of
GTP and Mg
2þ. At this point, half of the sample was
concentrated (leading towards sample 4) and incubated in
the presence of c-di-GMP overnight. The other sample was
incubated similarly without varying its concentration (leading
Figure 5. Reconstitution of a Product-Inhibited WspR
(A) Flow chart outlining the reconstitution experiments. Cyclic di-GMP–bound, inhibited WspR
wt (sample 1) (0.24 mM) was treated with PDE (sample
1b). The nucleotide-free, active dimer was repurified (sample 2). After incubation with GTP/Mg
2þ, the sample was split into two fractions. One fraction
was concentrated (to approximately 0.48 mM) and incubated overnight at 4 8C, the other was incubated under identical conditions at its initial
concentration (approximately 0.05 mM) (samples 3 and 4, respectively). Samples were subjected to SEC. At each step of the reaction cycle, samples were
analyzed for nucleotide content, their gel filtration profile, and enzymatic activity.
(B) Nucleotide loading states of WspR species. Proteins were analyzed as described above in Figure 2.
(C) Gel filtration profiles of WspR species. WspR
wt species indicated in Figure 5A were analyzed as described above (Figure 2C and 2D). Except for the
sample that was subjected to a final concentration (sample 4), the concentration of WspR (initially at 0.24 mM) decreased along the reaction scheme
due to preparative gel filtration steps. The inset shows concentration-dependent oligomerization behavior of nucleotide-free WspR. WspR
wt: nuc.-free
(dashed line: 0.08 mM; solid line: 0.24 mM; initial concentration) was analyzed by SEC. Peak maxima are at 11.7 and 13.3 ml elution volume.
(D) Enzymatic activity of WspR species. Catalytic activities of WspR species (0.5 lM) were determined in a continuous assay measuring pyrophosphate
production as described in Figure 4B. Initial velocities were determined by linear regression. Error bars indicate standard deviations of three
independent experiments.
(E) Structural and functional characteristics of distinct WspR states. The table summarizes properties of distinct WspR species along the reconstitution
path.
doi:10.1371/journal.pbio.0060067.g005
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and peak fractions were analyzed by analytical gel ﬁltration
and HPLC analysis (Figure 5B and 5C). The mobility of the
sample that had not been subjected to a concentration step
(sample 3; olive trace) was unchanged compared to the
nucleotide-free species despite c-di-GMP binding to the I-
site. In contrast, c-di-GMP–bound WspR
wt that was incubated
at higher protein concentration in the presence of nucleotide
(sample 4; yellow trace) eluted at the same position as the
original enzyme (sample 1; red trace), reminiscent of an
elongated, product-inhibited dimer.
When comparing enzymatic activities associated with the
distinct reaction states, we found that the product-inhibited
species was only reconstituted in the case where the protein
concentration was raised and thus facilitating tetramer
formation (sample 4) (Figure 5D and inset in Figure 5C).
Despite c-di-GMP binding, the form of WspR
wt existing
predominantly as a compact dimer (sample 3) was highly
active similar to the nucleotide-free species, consistent with
the identical elution proﬁles (Figure 5D and 5E). Both
conditions, favoring tetramer formation and the presence
of c-di-GMP, were required for assembling the elongated,
inactive WspR dimer. We hypothesize that the tetramer serves
as a platform allowing the formation of the product-inhibited
state, and c-di-GMP serves as a coordinator as well as an
allosteric inhibitor in the ﬁnal conformation (see below).
Expression Levels of WspR Determine Its Enzymatic
Activity in Cells
All results discussed thus far have been obtained using a
puriﬁed system presenting evidence for a mechanism of how
WspR might integrate enzyme and product concentration to
modulate its activity state. To corroborate these ﬁndings in
cells, we adopted a phenotypic assay that correlates c-di-GMP
production with increased Congo Red (CR) staining charac-
teristic for cellulose production in E. coli [32,33]. E. coli BL21
transformed with the vector control (pET21) or WspR
GGAAF
remained uncolored when plated on CR-containing plates
(Figure 6A). In contrast, leaky expression of WspR
wt or
WspR
R242A in the absence of IPTG was sufﬁcient to cause a
red colony phenotype (Figure 6A and 6B). Increased IPTG-
induced protein expression impaired the morphotype, and
colonies remained uncolored. In contrast, the isolated
GGDEF domain was inactive at low expression levels, but
Table 1. Molecular Weight of WspR Determined by Coupled SEC/Multiangle Light Scattering
Protein Property PEAK 1
a PEAK 2 PEAK 3 Bound
Nucleotide
b
Diguanylate
Activity
c
Wild-type n.d. n.d. c-di-GMP þ
Molecular weight 85.9 kDa
Elution volume 9.1–9.5 ml
Polydispersity 1.006 6 0.013
Wild-type (PDE-treated) n.d. n.d.   þþþ
Molecular weight 81.3 kDa
Elution volume 9.3–9.9 ml
Polydispersity 1.002 6 0.005
GGAAF n.d.   
Molecular weight 162.7 kDa 79.7 kDa
Elution volume 8.8–9.1 ml 9.5–9.9 ml
Polydispersity 1.001 6 0.010 1.003 6 0.008
R198A n.d.   þþþ
Molecular weight 161.6 kDa 81.3 kDa
Elution volume 8.7–9.0 ml 9.4–9.9 ml
Polydispersity 1.024 6 0.053 1.003 6 0.009
R242A n.d.   þþþ
Molecular weight 162.1 kDa 78.6 kDa
Elution volume 8.7–9.0 ml 9.4–9.9 ml
Polydispersity 1.002 6 0.012 1.005 6 0.009
R198/242A n.d.   þþþ
Molecular weight 161.2 kDa 80.1 kDa
Elution volume 8.7–9.0 ml 9.4–9.9 ml
Polydispersity 1.005 6 0.051 1.005 6 0.015
L170D n.d. c-di-GMP þþ
Molecular weight 161.3 kDa 73.3 kDa
Elution volume 8.7–9.0 ml 9.5–9.8 ml
Polydispersity 1.005 6 0.006 1.009 6 0.016
L167Dd n.d. n.d. n.d. c-di-GMP  
The table shows representative results from at least two independent experiments. The theoretical molecular weight of monomeric, hexahistidine-tagged WspR is 39.2 kDa. For
normalization of the detectors, monomeric bovine serum albumin (BSA) was analyzed (theoretical molecular weight: 66.4 kDa; molecular weight by light scattering: 70.4 kDa;
polydispersity: 1.003 6 0.009).
aTetramers are clearly detectable as indicated, with dimers being the predominant species at the given concentration. PDE-treated WspR
wt is exclusively dimeric, but tetramerization can
be induced upon increase in protein concentration (see Results and Discussion).
bNucleotides were eluted from purified proteins by heat denaturation and analyzed by reverse-phase HPLC (see Material and Methods).
cDiguanylate cyclase activity was assayed by quantification of pryophosphate production (see Materials and Methods).
dWspR
L167D elutes between 9.8–10.2 ml with a molecular weight of 55.0 kDa (polydispersity index¼1.015 6 0.011), suggesting that the proteins resides predominantly in the monomeric
state (with some dimer fraction).
doi:10.1371/journal.pbio.0060067.t001
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Structure and Regulation of WspRCR staining was detectable upon induction with IPTG,
suggesting that bulk protein expression is sufﬁcient for the
formation of transient functional complexes.
Based on the analysis by gel ﬁltration of lysates from E. coli
expressing WspR
wt at low and high levels, it was evident that
an increase in protein expression was accompanied by a shift
in hydrodynamic radius of WspR
wt. Upon IPTG induction,
WspR
wt shifted from a compact dimer at low expression to a
species with a peak eluting at a similar position as the puriﬁed
c-di-GMP–bound elongated dimer (Figure 6C). The elution
behavior was distinct from that of puriﬁed WspR
GGAAF that
eluted as a tetramer-compact dimer mixture (Figure 6C and
Table 1). We hypothesize that WspR
R242A forms tetramers at
high protein concentrations in cells in which the active sites
are blocked, therefore inhibiting the morphotypic changes.
Gel ﬁltration experiments starting with lysates from
WspR
R242A- or WspR
GGAAF-expressing cells showed predom-
inantly the more compact, dimeric species, probably due to
the dilution occurring during chromatographic separation
(unpublished data).
Taken together, the basic mechanism of product inhibition
and conformational switching of WspR derived from the
structural and functional studies appears to be effective in
cells.
Model for the Inhibition and Activation of WspR
The gel ﬁltration and multiangle light-scattering experi-
ments demonstrated that in solution, c-di-GMP-inhibited
WspR is predominantly an elongated dimer, distinguishable
from an active dimer with a more globular shape and from a
tetrameric species (Figure 3). The reconstitution experiment
showed that the tetramer serves as a scaffold that assembles
from the active, compact dimer and dissociates into the
elongated, inhibited dimer (Figures 7 and 8A). The crystallo-
graphic tetramer assembled from this elongated, dimeric
WspR, and hence, we hypothesize that the model contains
structural information about both dimeric states. We already
discussed a suggestive active dimer conformation (see above;
Figure 1B) and will now propose a model for the elongated
dimeric state.
Although three possible elongated WspR dimers can be
derived from the tetrameric structure (Figure S4C), the dimer
shown in Figure 8A (right panel) might represent a structure
close to the conformation of inactive WspR in solution
(elongated dimer 1 in Figure S4C), based on structural and
functional arguments. A detailed rationale is provided as
supplemental information (Figure S3C, ﬁgure legend), and we
will concentrate on the description of the mechanistically
most plausible model (Figure 8A).
There are many considerations that support elongated
dimer 1 as the inhibited state (Figures 8A and S4C):
Structurally, such a dimer can be readily obtained from the
tetrameric assembly by a dissociation of the two planes
consisting of the colored (chain A) and the grey (chain B)
molecules, respectively (Figure 8A). Such segregation would
be accompanied by the breakup of the CheY dimer. This
would require a simple rigid body rotation of the stalk-CheY
unit in the dimer shown in grey (arrows in Figure 8A, middle
panel) that is similar to the rotation shown in Figure 1C. The
breakup of the CheY dimer interface would be thermody-
namically facilitated by new interactions formed between the
GGDEF domain and the CheY-stalk unit of neighboring
Figure 6. Catalytic Activity and Oligomerization of WspR in Cells
(A) Congo Red (CR) assay monitoring WspR-catalyzed c-di-GMP
production in cells. E. coli BL21 were transformed with plasmids
encoding wild-type or mutant variants of WspR. Cells were grown to
mid-log phase at 37 8C, and 2.5 ll of the culture was spotted onto a CR-
containing LB plate with or without IPTG and incubated for 24 h at 30 8C.
Leaky expression in the absence of IPTG and IPTG-induced WspR
expression was visually assayed for a red colony phenotype (rdar
morphotype). Cells expressing an untagged version of WspR
wt behave
similarly to cells expressing WspR with a C-terminal hexahistidine tag.
(B) Loss of CR staining correlates with high WspR expression levels.
Cultures were grown for 16 h at 25 8C in the absence or presence of IPTG.
Lysates from cells expressing hexahistidine-tagged wild-type and mutant
variants of WspR (see above) were prepared by sonication and analyzed
by western blotting using a hexahistidine tag-specific antibody to detect
recombinant protein. Samples were normalized to total protein amount
prior to SDS-PAGE and blotting. Western blot detection of the native E.
coli protein LexA was used as a control. LexA levels were slightly lower in
some samples due to high WspR expression levels obscuring total
protein normalization.
(C) Gel filtration profile of WspR in cell lysates. Cell lysates were subjected
to SEC in gel filtration buffer. Fractions (0.1 ml) were collected, and
hexahistidine-tagged proteins in the fractions were detected by western
blotting. Elution profiles were compared to profiles obtained for purified
proteins (c-di-GMP–bound WsrR
wt or nucleotide-free WspR
GGAAF) under
identical conditions.
doi:10.1371/journal.pbio.0060067.g006
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proposed dimer interface is the most extensive one of the
three possible dimer states (;2,430 A ˚ 2 surface area buried;
Figure S4C) and is spread over the entire molecule, including
an antiparallel packing of the stalks, in addition to the
aforementioned interactions (zones 1–3 in Figure 8A, right
panel). The GGDEF-stalk interface (zone 2) is centered
around an ionic bond between residues E253 from the active
site GGEEF motif and R151 in the stalk of an adjacent
protomer (Figure S4C, inset). In addition to stabilizing the
antiparallel assembly, this interaction would contribute to the
inhibition mechanism by sequestering the active site, with c-
di-GMP bound at the back of the b-sheets connecting the
GGEEF motif-containing loop serving as an allosteric
inhibitor, in agreement with a model for c-di-GMP–mediated
inhibition proposed recently [20]. Altogether, such a con-
formation would leave the CheY-homology domains unpaired
and available for dimerization, whereas the GGDEF domains
are far apart from each other in a catalytically incompetent
state.
The linkage between the GGDEF domain and the CheY-
stalk module is likely to be rather ﬂexible, as evidenced by the
differences observed between the two molecules in the
asymmetric unit (Figure 1C). For both the models of the
active and inactive dimers, the exact position of the GGDEF
domains relative to the CheY-stalk module might be different
from that observed in the tetrameric assembly, and might
depend on interactions with nucleotides, inter- and/or
intramolecular interactions. Further studies will be needed
to determine the exact conformations of these states.
Conclusion
The diguanylate cyclase WspR, a response receiver that
controls bioﬁlm formation in Pseudomonas, is subject to a
surprisingly sophisticated mode of regulation, considering its
rather straightforward domain organization. The autoregu-
latory switch in WspR involves a coiled-coil motif extending
from the CheY-homology phospho-receiver domains. This
helical stalk can homodimerize in a parallel or antiparallel
fashion, stabilizing the active or inactive state, respectively
(Figure 8A). Since the tetramer assembles from the compact
dimeric species and dissociates into elongated dimers in the
presence of c-di-GMP, it is not surprising that the structure
captures features from all three states. As a required
intermediate, a tetrameric assembly serves as an exit platform
for the product-inhibited species. Tetramerization is also
driven by interactions of the stalks, jamming the active sites
and establishing transient inhibition.
We recently obtained a crystal structure of the WspR
homolog from P. syringae (R. Raghavan and H. Sondermann,
unpublished data). In this crystal, WspR was also found in a
tetrameric assembly similar to the one described here with a
subtle, but important, difference. The inhibitory contacts
between all four GGDEF domains and the CheY-stalk
modules of the neighboring protomers have been formed
(similar to zone 2 in Figure 8A). It was rewarding to see that
this leads to a weakening of the CheY domain interfaces
(unpublished data), supporting our hypothesis that the
tetramer facilitates the formation of elongated, inactive
dimers with unpaired CheY domains.
Previously, it has been demonstrated that WspR is
regulated by phosphorylation in vivo [23,24,34]. In the
puriﬁed system, mutant proteins targeting the active site of
the CheY domain have characteristics indistinguishable from
WspR
wt (unpublished data). Furthermore, puriﬁed WspR
appears to be constitutively oligomeric even in the absence
of posttranslational modiﬁcations under the conditions
described here (Table 1; Materials and Methods). Constitu-
tive, phosphorylation-independent dimerization has been
shown recently for HP-RR, a response regulator from
Helicobacter pylori [35], and might apply more widely to other
CheY-homology domain–containing proteins.
Although the compact, active dimer state and the regu-
latory mechanism appear not to require phosphorylation of
the CheY domains, we do not rule out that it might have an
effect on WspR function. In fact, preliminary studies suggest
that addition of beryllium ﬂuoride, a commonly used
compound mimicking phosphorylation, modulates WspR’s
oligomeric state, facilitating tetramer formation and auto-
inhibition (N. De and H. Sondermann, unpublished data). In a
Figure 7. Model for the Feedback Regulation and Reactivation of WspR
Based on structural and functional analyses, a model is proposed in which active WspR dimers are in equilibrium with a transient tetrameric species that,
in the presence of c-di-GMP, provides an exit platform for the product-inhibited elongated dimer. Degradation of c-di-GMP by PDEs triggers a snapping
back to the active dimer species, probably avoiding the tetrameric state. Both c-di-GMP binding and tetramerization are required for the assembly of
the inhibited species. It is unlikely that the tetrameric state is en route from the inhibited to the active dimer, which would require dissociation of the
tetramer once c-di-GMP has been degraded. Experimentally, we did not observe any tetramers immediately after PDE treatment, and the tetrameric
species arises only after prolonged incubation of the compact, but not the elongated dimer (Table 1, see also Figures 2C, 3, and 5).
doi:10.1371/journal.pbio.0060067.g007
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Structure and Regulation of WspRFigure 8. Distinct Oligomeric Conformations of WspR and Mechanistic Implication for the Regulation of GAF Domain-Containing Proteins
(A) Structural models closely resembling the distinct states of WspR. The solvent-accessible surface of a WspR dimer is shown. In the active state (left
panel), dimerization is mediated by the CheY-homology domains and protruding stalks. The stalks may convene in the fully active state bringing the
GGDEF domains into close proximity (arrow in left panel). In the tetrameric assembly that serves as an intermediate between the two dimeric states
(middle panel), two C2-symmetry–related crystallographic dimers of WspR are shown intertwined in a head-to-head orientation. ‘‘S’’ or ‘‘SYM’’ in the
cartoon diagram indicates crystal symmetry–related molecules. The stalks form a tetrameric structure splaying apart the coiled-coils and physically
blocking the active sites. Cyclic di-GMP molecules bound at the I-site bridge the GGDEF domains of neighboring molecules. Arrows indicate how
breaking up the CheY domain dimer by a rigid body rotation of the CheY-stalk module would facilitate the formation of two identical dimers shown in
the right panel. In the proposed model for the product-inhibited state, dimers of two symmetry-related molecules (chain A) are held together by three
interfaces between the tip of the stalks (zone 1), between the GGDEF domain and the stalk (zone 2), and between the GGDEF domain and the CheY
domain (zone 3) of adjacent molecules. Such dimers can be readily obtained from the tetramer by segregation of a plane consisting of the colored
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Structure and Regulation of WspRputative model, the activated, phosphorylated state may be
subject to stronger feedback regulation via tetramerization.
Such a mechanism would create a short c-di-GMP pulse
before WspR shuts down contributing to localized signaling, a
hallmark described for this second messenger signaling [36].
On another level, WspR has been shown to relocalize in a
phosphorylation-dependent manner [37]. It is feasible that
phosphorylation is used for ﬁne-tuning of the signaling
system. The proper output might rely on the exact spatial and
temporal activation of WspR and regulation might impact
both localization and/or activity. The exact mechanism and
role of phosphorylation on WspR activity awaits further
experimental elucidation.
The switching mechanism in WspR involving distinct
oligomers might be more widely used, and may apply to
other regulatory domains such as GAF domains, a common
regulatory module in cyclic nucleotide PDEs. Tandem GAF
units contain two globular nucleotide-binding domains
connected by a helical stalk. They have been crystallized in
two conformations, a parallel and an antiparallel dimer
[38,39]. In the structure of mouse PDE2A, the N-terminal
GAF domain and the protruding stalk function as a
dimerization module (Figure 8B, left panel) [39]. Interestingly,
we ﬁnd a tetrameric assembly in the crystal lattice in which
the stalk dimers and the second GAF domains bind in a head-
to-head orientation (Figure 8B, right panel). In essence, these
conformations show remarkable resemblance to the compact
dimer and the tetramer species of WspR (Figure 8). In
contrast, the tandem GAF domain from Anabaena forms an
antiparallel assembly in the crystal lattice (Figure 8C) [38],
globally resembling the elongated dimer of WspR (Figure 8).
We speculate whether a similar oligomerization mechanism
as the one we describe here for WspR might also regulate
GAF domain–containing phosphodiesterases in all kingdoms
of life.
In our model for feedback regulation of WspR, c-di-GMP
serves two purposes: Initially, it works as a clamp in the
tetramer that stabilizes a conformation from which the
inactive dimers detach. Cyclic di-GMP remains bound to
the canonical I-site motif located solely at the GGDEF
domain, where it functions as an allosteric inhibitor [20].
The inhibited dimeric state is primed for (re)activation.
Removal of c-di-GMP from the I-site by PDEs releases the
inhibition and induces dimerization of the unpaired CheY-
homology domains and diguanylate cyclase activity via
switching between distinct dimer species. Using puriﬁed
enzymes, we did not observe a high degree of speciﬁcity;
multiple active PDEs showed similar activities towards WspR-
bound c-di-GMP. In cells, targeting and signaling speciﬁcity
might be determined by regulatory domains in the PDEs. In
summary, activation by PDEs might represent a more general
way to switch on diguanylate cyclases, in addition to the well-
established phosphorylation-dependent mode.
The feedback mechanism described here allows WspR to
integrate multiple inputs such as phosphorylation, as well as
protein and c-di-GMP concentrations, to adjust its activity.
The mode of regulation is likely to be relevant with regards to
the particular properties of c-di-GMP signaling in bacteria.
Despite its small size and hydrophilic nature, c-di-GMP
appears not to function as a general, diffusive second
messenger in the cell. Mutation and overexpression of
individual diguanylate cyclases and phosphodiesterases in
Pseudomonas lead to distinct cellular responses for the
particular enzymes, affecting either bioﬁlm formation, type
III-secretion system-mediated cytotoxicity, or both [17].
Rather than triggering pleiotropic signaling, responses
appear to be spatially restricted, probably depending on the
localization of the enzymes producing or turning over c-di-
GMP [36,40,41]. Both displaying an inhibitory site with high
afﬁnity for c-di-GMP on the cyclases themselves, and
mechanisms for sensing and reacting to the local enzyme
concentration can contribute to spatial restriction of the
signal.
All residues involved in higher-order oligomerization, c-di-
GMP binding, and catalysis are strictly conserved across
various Pseudomonas strains (Figure S1). It is interesting to
note that a subset of Burkholderia (Burkholderia sp. 383, ambifaria
MC40–6, and vietnamiensis G4) contains a point mutation in a
residue critical for c-di-GMP binding at the I-site (R242;
Figures S1 and 1E). These Burkholderia species are frequently
found in cystic ﬁbrosis patients with pulmonary infections
[42]. It will be interesting to see whether the substitution in
t h eI - s i t eo fW s p Ra n dc - d i - G M Ps i g n a l i n gi ng e n e r a l
contribute to virulence mechanism of microorganisms. More
extensive analyses of the genomes from clinical isolates, in
combination with thorough mechanistic studies, will be
required to establish a link of pathogenicity and altered
activities of enzymes involved in c-di-GMP signaling.
Many processes, including bacterial bioﬁlm formation,
contribute to the pathogenicity of microorganisms and high
mortality rate from infectious diseases [43]. Bioﬁlms have
been shown to be the leading cause for chronic infections
such as Legionnaire’s disease, infections of the heart and ear,
and infections accompanied with cystic ﬁbrosis, to name only
a few prominent examples [44–46]. Often, bacterial bioﬁlms
escape efﬁcient treatment due to the development of
tolerance or resistance to antibiotics [15]. Identifying the
molecules and mode of action contributing to pathogenesis,
molecules (chain A dimer) from a plane formed by the grey molecules (chain B dimer). The maximal dimensions and surface areas buried at the
interfaces are shown.
(B) Dimeric and tetrameric assembly seen in the mouse PDE2A tandem GAF domain crystal structure. The molecule in the asymmetric unit and a
symmetry-related molecule (indicated by apostrophes) form a dimer via pairing of their GAF A domains (PDB code 1MC0) [39]. In the crystal, the tips of
the stalks that connect the GAF A and GAF B domains are splayed apart by a symmetry-related dimer (see tetrameric structure). Cyclic GMP is bound
only to the GAF B domains. The tetrameric assembly consists of two additional symmetry mates (indicated by asterisks). The two symmetry-related
crystallographic dimers are intertwined in a head-to-head orientation with the stalks forming a tetrameric structure via their split ends. In such an
assembly, significant interfaces for the dimer–dimer interaction are formed between the stalks, between the GAF B domains, and between the GAF A
and B domains of adjacent chains. GAF A domains are colored blue and light blue, GAF B domains are colored violet and light violet, and the stalks are
shown in orange and grey.
(C) Crystal structure of the tandem GAF domain dimer from the adenylate cyclase cyaB2 in Anabaena. The two tandem GAF domain molecules in the
asymmetric unit form an antiparallel dimer mediated in part by the helical stalks connecting the GAF A and B domains (PDB code 1YKD) [38]. Cyclic AMP
is bound to both GAF A and B domains of cyaB2. The coloring scheme in (B) has been applied for straightforward comparison of relative domain
orientations.
doi:10.1371/journal.pbio.0060067.g008
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turnover, provides the foundation for novel strategies in
the treatment of infections [17,47]. Given the absence of c-di-
GMP signaling in eukaryotic cells, this pathway might be an
attractive therapeutic target and mechanistic studies will
facilitate the development of novel antibiotics in this regard.
Materials and Methods
Protein expression and puriﬁcation. The coding region corre-
sponding to full-length WspR [24,48] was ampliﬁed by standard PCR
using genomic DNA isolated from P. aeruginosa PAO1 (locus tag
PA3702), P. syringae DC3000 (locus tag PSPTO_1499), P. ﬂuorescence
PfO-1 (locus tag Pﬂ_1058), or P. putida KT2440 (locus tag PP_1494),
and was cloned into the pET21 expression plasmid (Novagen),
yielding a C-terminally hexahistidine-tagged protein.
Transformed E. coli cells BL21(DE3) (Novagen) were grown in TB
medium supplemented with 100 mg/l ampicillin at 37 8C. At a cell
density corresponding to an absorbance of 1.0 at 600 nm, the
temperature was reduced to 18 8C, and protein production was
induced with 1 mM IPTG. Protein was expressed for 12–16 h. Cells
were collected by centrifugation, resuspended in NiNTA buffer A (25
mM Tris-Cl [pH 8.2], 500 mM NaCl, 20 mM imidazole, and 5 mM 2-
mercaptoethanol). After cell lysis by sonication, cell debris was
removed by centrifugation at 40,000 3 g for 1 h at 4 8C. Clear lysates
were loaded onto HisTrap NiNTA columns (GE Healthcare)
equilibrated in NiNTA buffer A. The resin was washed with 20
column volumes of NiNTA buffer A, and proteins were eluted on a
gradient from 20 to 500 mM imidazole in NiNTA buffer A over 15
column volumes. Proteins were further subjected to SEC on a
Superdex200 column (GE Healthcare) equilibrated in gel ﬁltration
buffer (25 mM Tris-Cl [pH 7.5], 100 mM NaCl, and 1 mM DTT).
Fractions containing protein were pooled and concentrated on a
Centricon ultraﬁltration device (30 kDa cutoff; Millipore) to a ﬁnal
concentration of approximately 50 mg/ml. Protein aliquots were
frozen in liquid nitrogen and stored at  80 8C.
Puriﬁed WspR with a C-terminal hexahistidine tag was analyzed by
liquid chromatography/electrospray ionization mass spectrometry.
The protein is free of detectable posttranslational modiﬁcations with
a measured molecular weight (39,165.6 Da) in good agreement with
the theoretical molar mass (39,165.4 Da).
Full-length SadR/RocR/PA3947 from P. aeruginosa PAO1 [49,50] was
ampliﬁed as described above and cloned into a modiﬁed pProExHTb
expression plasmid (Invitrogen), producing a Precision protease-
cleavable N-terminally hexahistidine-tagged protein. Expression and
puriﬁcation were performed as described above with the addition of
a Precision protease-cleavage step during puriﬁcation for removal of
the hexahistidine tag.
Nucleotide-free WspR
wt was prepared by treatment with the PDE
SadR/RocR in the presence of 2 mM MgCl2 in a dialysis setup
overnight at 4 8C. Progress was monitored by HPLC (see below). The
PDE was removed by rebinding of WspR
wt to NiNTA matrix followed
by elution and gel ﬁltration as described above.
Crystallization, X-ray data collection, and structure solution.
Crystals were obtained by hanging-drop vapor diffusion by mixing
equal volumes of protein (5–30 mg/ml) and reservoir solution (0.1 M
Tris-Cl [pH 8.0], 2.9 M NaCl, 15% xylitol) followed by incubation at
20 8C. Crystals appeared within 1 to 2 d, with typical dimensions of
0.2 mm 3 0.2 mm 3 0.2 mm. Crystals were ﬂash-frozen in liquid
nitrogen and kept at 100 K during data collection.
Crystallographic statistics for data collection are shown in Table
S1. Datasets were collected using synchrotron radiation at the Cornell
High Energy Synchrotron Source (CHESS, Ithaca, beamline A1). Data
reduction was carried out with the software package HKL2000 [51].
The space group was determined to be C2 with a¼144.5 A ˚ , b¼72.8 A ˚ ,
c ¼ 106.1.4 A ˚ , and b ¼ 110.88. The asymmetric unit consists of two
molecules, bound to four molecules of c-di-GMP and two magnesium
ions. Phases were obtained from molecular replacement with the
isolated GGDEF and CheY domains of PleD (PDB code: 1W25) [19] as
search models using the software package Phenix [52]. The model of
the WspR dimer was built manually starting from the molecular
replacement solution. Reﬁnement using CNS [53] and O [54] yielded
the ﬁnal model. Illustrations were made in Pymol (DeLano Scientiﬁc).
Diguanylate cyclase and phosphodiesterase activity assays. Two
experimental systems for assaying diguanylate cyclase activity in vitro
were used. A coupled spectrophotometric assay quantiﬁes the
amount of inorganic pyrophosphate, a product of the cyclization
reaction, in solution (EnzChek Pyrophosphate Assay; Invitrogen) [55].
It relies on two enzymes, a pyrophosphatase that cleaves the
pyrophosphate bond, producing two molecules of inorganic phos-
phate, and a purine nucleoside phosphorylase that converts 2-amino-
6-mercapto-7-methylpurine ribonucleoside to ribose-1-phosphate
and 2-amino-6-mercapto-7-methylpurine in a phosphate-dependent
manner. Pyrophosphate production was monitored by a shift in the
absorption peak from 330 nm to 360 nm. If not otherwise noted,
WspR (0.5 lM) was incubated in the assay buffer containing 0.5 mM
GTP and 2 mM MgCl2.
The second assay uses reverse-phase HPLC to separate nucleotides
for the determination of nucleotide loading states of puriﬁed
proteins and for the analysis of reaction products after incubation
of proteins in the presence of 0.5 mM GTP and 2 mM MgCl2.
(established by Abhishek Chatterjee, Cornell). Proteins were heat
denatured at 95 8C for 5 min, followed by centrifugation for 10 min at
14,000 rpm. Supernatants were ﬁltered through Microcon Centrifu-
gal Filter units (Millipore) with a 10-kDa cutoff. Nucleotides were
separated on a C18 reverse-phase column using a methanol-
phosphate gradient (buffer A: 100 mM potassium phosphate [pH
6.0]; buffer B: 30% methanol/70% buffer A). Reaction products were
collected and identiﬁed by comparison to standard nucleotides or by
mass spectroscopy. Synthetic c-di-GMP was purchased from Biolog.
Size-exclusion chromatography and SEC-coupled multiangle light
scattering. Puriﬁed protein (approximately 0.08 mM) was subjected to
SEC using a Superdex 200 10/300 column (GE Healthcare) equili-
brated in gel ﬁltration buffer (25 mM Tris-Cl [pH 7.5], 100 mM NaCl,
and 1 mM DTT).
For SEC-coupled multiangle light scattering [31], puriﬁed protein
(approximately 0.1 mM) was subjected to SEC using a Shodex KW-803
column (JM Science) equilibrated in gel ﬁltration buffer. The
chromatography system was coupled to an 18-angle light-scattering
detector (DAWN EOS) and refractive index detector (Optilab DSP)
(Wyatt Technology). Data were collected every 0.5 s at a ﬂow rate of
0.4 ml/min. Data analysis was carried out using the program ASTRA,
yielding the molar mass and mass distribution (polydispersity) of the
sample. For normalization of the light-scattering detectors and data
quality control, monomeric bovine serum albumin (BSA; Sigma) was
used.
Cell-based diguanylate cyclase assay. E. coli BL21(DE3) transformed
with expression plasmids were grown in LB media supplemented with
100 mg/l ampicillin to a cell density corresponding to an absorbance
of 0.5 at 600 nm. From each culture, 2.5 ll was spotted onto LB plates
supplemented with 100 mg/l ampicillin, 50 mg/l Congo Red (CR;
Sigma-Aldrich), and IPTG at the indicated concentrations. Plates
were incubated at 30 8C overnight.
Puriﬁed proteins and cell lysates were analyzed by SEC on an
analytical-scale Superdex200 10/300 column (GE Healthcare) equili-
brated in gel ﬁltration buffer. Fractions were analyzed by SDS-PAGE
followed by Coomassie Blue staining or detection of the hexahistidine
tag by western blotting.
Supporting Information
Figure S1. Sequence Conservation of WspR in Pseudomonas and
Related Species
Sequence alignment of WspR. The sequence alignment of WspR
proteins from various Pseudomonas and related species was generated
using ClustalW [56] and formatted with ESPript using the Web server.
Residues discussed in the text are highlighted with asterisks and
arrows. The position of the conserved GGEEF motif (residues 251–
255 in WspR from P. aeruginosa) is underlined (yellow box). Residues
140 to 171 have been predicted to form coiled-coil-like structures by
multiple algorithms (http://www.expasy.org) (orange box). The follow-
ing sequences were used to generate the alignment: P. aeruginosa
PAO1, P. entomophila L48, P. ﬂuorescens Sbw25, P. ﬂuorescens PfO-1, P.
ﬂuorescens Pf-5, P. putida W619, P. syringae pv. syringae B728a, P. syringae
pv. phaseolicola 1448A, P. syringae pv. tomato str. DC3000, Ralstonia
metallidurans CH34, R.eutropha H16, Burkholderia phymatum STM815, B.
dolosa AUO158, B. phytoﬁrmans PsJN, Mesorhizobium loti MAFF303099,
Burkholderia sp. 383, B. ambifaria MC40–6, and B. vietnamiensis G4.
Found at doi:10.1371/journal.pbio.0060067.sg001 (2.9 MB TIF).
Figure S2. Electron Density Maps of c-di-GMP-Bound WspR
wt
(A) Electron density for the helical linker regions that connect the
CheY and GGDEF domains of WspR at 2.40 A ˚ . The electron density
map shown has amplitudes of (jFoj j Fcj), with Fo and Fc being the
PLoS Biology | www.plosbiology.org March 2008 | Volume 6 | Issue 3 | e67 0614
Structure and Regulation of WspRobserved and calculated structure factors. Phases were obtained by
molecular replacement. The electron density contour is at 2.4 r.
(B) Electron density for c-di-GMP at the I-site of the GGDEF domain.
The electron density map shown has amplitudes of (jFoj j Fcj), with
Fo and Fc being the observed and calculated structure factors. The
electron density contour is at 3 r.
Found at doi:10.1371/journal.pbio.0060067.sg002 (1.6 MB TIF).
Figure S3. Comparison of WspR with Structures of PleD and the
Phospho-Receiver Domain Dimer of PhoB
(A) Comparison of WspR with the structure of CheY domains of PhoB
from E. coli. The structures of the CheY-homology domain dimer of
WspR (residues 1–140) and a CheY domain dimer of PhoB (PDB code
1ZES) [26] were structurally aligned through superpositioning the
CheY domain dimers.
(B) Comparison of dimeric WspR with the structure of PleD from C.
crescentus. The structures of a WspR dimer (residues 1–140) and
monomeric PleD (PDB code 1W25) [19] were aligned through
superpositioning the CheY-homology domain dimer of WspR onto
the intramolecular CheY-homology domain dimer of PleD.
(C) Comparison of tetrameric WspR with the monomeric and
dimeric, activated structures of PleD from C. crescentus. The structures
of monomeric PleD (left; PDB code 1W25) [19], and dimeric PleD
(middle; PDB code 2V0N) [22] and WspR (right) are shown.
Found at doi:10.1371/journal.pbio.0060067.sg003 (2.6 MB TIF).
Figure S4. Structures Depicting Proposed Models for the Active,
Intermediate, and Product-Inhibited State of WspR Driven by Stalk
Interactions
(A) Proposed structure closely resembling an active state of WspR.
The two molecules in the asymmetric unit form a dimer via pairing of
their CheY-like phospho-receiver domains reminiscent of an active
CheY dimer [26]. In the crystal, the tips of the stalks are splayed apart
by a symmetry-related dimer (see [B]). Sequence-based analysis
predicts a bona ﬁde coiled-coil structure for residues 140–171
(Figure S1), suggesting that the stalks might convene in the active
conformation bringing the GGDEF domains into close proximity.
The boxed areas correspond to the close-up views shown in (D). The
maximal dimensions for the various complexes are shown.
(B) Tetrameric assembly consisting of two symmetry-related dimers.
Two C2-symmetry–related crystallographic dimers of WspR are
shown intertwined in a head-to-head orientation. The stalks form a
tetrameric structure splaying apart the coiled-coils and physically
blocking the active sites. The GGDEF domains are linked via c-di-
GMP molecules that bridge the I-sites of neighboring molecules.
Arrows indicate how breaking up the CheY domain dimers
accompanied by a rigid body rotation of the CheY-stalk module
would facilitate the formation of two identical dimers shown in (C)
(elongated dimer 1). Such a motion is similar to the one shown in
Figure 1C.
(C) Possible elongated dimer states derived from the tetrameric
assembly. Cyclic di-GMP-bound, inactive WspR is dimeric in solution
but crystallizes as a tetrameric assembly. From the three possible
elongated WspR dimers that can be derived from the tetrameric
structure (Figure S4B), the elongated dimer 1 (also shown in Figure
8A, right panel) might represent a structure close to the conforma-
tion of inactive WspR in solution, based on structural and functional
arguments presented in the main text. Brieﬂy, two symmetry-related
molecules shown in color (chain A) of WspR in the elongated dimer 1
are held together by three interfaces: stalk-stalk, stalk-GGDEF
domain, and GGDEF domain-CheY domain of adjacent molecules.
In the stalks, the same residues that would satisfy the coiled-coil and
drive tetramerization form the hydrophobic center of the dimer (D–
F). The ionic interaction between the GGEEF motif and the stalk is
shown in detail (close-up view in inset). Elongated dimer 2 is
mediated exclusively by antiparallel packing of the stalks, burying the
smallest surface area in the dimer interface compared to dimers 1
and 3. Other interactions observed in elongated dimer 1 have not
formed yet in elongated dimer 2. Considering the bridging of the
GGDEF domains by c-di-GMP, elongated dimer 3 might be an
intuitive candidate for the inhibited state (Figure S4C, right panel).
However, the dissociation of such a dimer from the tetramer would
be sterically hindered. In addition, the buried surface area at the
interface (1,518 A ˚ 2 surface are buried between the two chains, 830 A ˚ 2
of which are buried between the GGDEF domains) is less extensive
compared to elongated dimer 1 (2,430 A ˚ 2), and the interaction
between the GGDEF domains appears to be functionally less
important since a mutation at the interface (WspR
R195E) has no
effect on the protein, being mechanistically indistinguishable from
wild-type WspR (unpublished data). These arguments and consid-
erations support the hypothesis that elongated dimer 1 might
represent a conformation close to the inhibited state in solution
that assembled to the tetrameric assembly in the crystal lattice.
Buried surface areas were calculated in CNS [53].
(D) Close-up view of the tip of the stalks considering a compact dimer
state. Asterisks indicate residues targeted for site-directed muta-
genesis (see Figure S6). The arrow indicates how the coiled-coil might
convene in the active state.
(E) Close-up view of the tip of the stalks in the tetrameric state. The
area boxed in (B) is shown as a close-up view. Leucine 170 (green
sphere) and leucine 167 (pink sphere) are colored as in (D).
(F) Close-up view of the tip of the stalks in an antiparallel, elongated
dimer 1. The area boxed in (C) is shown as a close-up view.
Found at doi:10.1371/journal.pbio.0060067.sg004 (2.3 MB TIF).
Figure S5. Conservation of the Oligomeric Switching Mechanism in
WspR from Other Pseudomonas Species
(A) Sequence conservation mapped onto the surface of WspR. The
structure of a WspR dimer is shown. The surface of molecule A is
shown and presented as a color gradient from green to grey to red
(0%–100% sequence conservation). Identical residues are colored in
red. Molecule B is shown as grey Ca trace.
(B) ClustalW scores for pairwise comparisons of WspR sequences
from P. aeruginosa, putida, ﬂuorescence, and syringae. Protein sequence
identities of WspR species analyzed in (C–E) were calculated using
ClustalW [56].
(C) Detection of guanosine nucleotides bound to WspR by a reverse-
phase HPLC-based assay. Chromatograms for pure c-di-GMP (stand-
ard) are shown as dashed, light-grey line. WspR
wt from the indicated
Pseudomonas species expressed in E. coli puriﬁes with c-di-GMP bound
(red trace). Nucleotide-free WspR
wt was obtained by including PDE
treatment in the puriﬁcation protocol followed by removal of pGpG
(green trace).
(D) PDE treatment triggers a conformational change in WspR.
Proteins were analyzed by SEC. Cyclic di-GMP–bound WspR
wt (0.24
mM) (red trace) was incubated with PDE (0.008 mM) in gel ﬁltration
buffer supplemented with 10 mM Mn
2þ for 2 h at 25 8C (dark-grey
trace). Nucleotide-free WspR
wt was further puriﬁed by removal of
PDE and pGpG, followed by preparative gel ﬁltration and concen-
tration (green trace).
(E) Comparison of enzymatic activity of c-di-GMP-bound and
nucleotide-free WspR. Nucleotide-bound (red bars) or nucleotide-
free (green bars) WspR
wt (0.5 lM) was incubated at 25 8C in assay
buffer (EnzChek Pyrophosphate Assay; Invitrogen) and pyrophos-
phate production was measured by continuously monitoring absorb-
ance at 360 nm. Error bars indicate standard deviations of three
independent experiments.
Found at doi:10.1371/journal.pbio.0060067.sg005 (1.9 MB TIF).
Figure S6. Characterization of Stalk Mutants of WspR
(A) Close-up view of the stalk region in the tetrameric assembly of
WspR. In the crystal, two WspR dimers interact in a head-to-head
fashion involving the tip of the stalk regions. Leucine residues
targeted for mutagenesis (changed to aspartates; L170D and L167D)
are central to the interactions driven by the stalks in the dimeric and
tetrameric assemblies (see Figure S4).
(B) Stalk mutants of WspR purify c-di-GMP bound. Nucleotides
bound to proteins with mutations at the tip of the stalks (WspR
L170D
or WspR
L167D; purple and blue trace, respectively) expressed in E. coli
were analyzed using a reverse-phase HPLC assay.
(C) SEC proﬁles of mutant and wild-type WspR. Nucleotide-bound
and nucleotide-free WspR
wt (red and green trace, respectively),
WspR
L170D (purple trace), and WspR
L167D (blue trace) (0.24 mM) were
analyzed by analytical gel ﬁltration in gel ﬁltration buffer. Maximum
peak heights correspond to elution volumes of 11.7, 12.1, and 13.3 ml.
(D) Comparison of enzymatic activity of wild-type and mutant forms
of WspR. WspR
wt (nucleotide-bound or -free) or mutant variants
(WspR L170D or WspRL167D) (0.5 lM) were incubated at 25 8C in assay
buffer (EnzChek Pyrophosphate Assay; Invitrogen) and pyrophos-
phate production was measured by continuously monitoring absorb-
ance at 360 nm. Coloring corresponds to the scheme shown in (C).
Error bars indicate standard deviations of three independent
experiments. Although WspR
L167D is predominantly monomeric
and has no activity under the conditions used here, it puriﬁes with
c-di-GMP bound. Upon overexpression, protein levels are likely to be
high enough to facilitate the formation of transient dimers exhibiting
diguanylate cyclase activity, similar to the activity observed for the
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not shown).
Found at doi:10.1371/journal.pbio.0060067.sg006 (1.3 MB TIF).
Table S1. Data Collection and Reﬁnement Statistics
Found at doi:10.1371/journal.pbio.0060067.st001 (44 KB DOC).
Accession Numbers
Atomic coordinates and structure factors for P. aeruginosa PA3702
have been deposited in the RCSB Protein Data Bank (http://www.rcsb.
org/pdb) under ID code 3BRE.
The National Center for Biotechnology Information (NCBI) (http://
www.ncbi.nlm.nih.gov) accession numbers for the protein sequences
used for alignment of WspR are as follows: Burkholderia sp. 383
(YP_372775), B. ambifaria MC40–6 (ZP_01553618), B. dolosa AUO158
(ZP_00984936), B. phytoﬁrmans PsJN (ZP_01511812), B. vietnamiensis
G4 (YP_001117051)., B. phymatum STM815 (ZP_01501464), Mesorhi-
zobium loti MAFF303099 (NP_109384), P. aeruginosa PAO1
(NP_252391), P. entomophila L48 (YP_606955), P. ﬂuorescens Pf-5
(YP_258266), P. ﬂuorescens PfO-1 (YP_346790), P. ﬂuorescens Sbw25
(AAL71852), P. putida W619 (ZP_01639796), P. syringae pv. phaseo-
licola 1448A (YP_276013), P. syringae pv. syringae B728a
(YP_234398), P. syringae pv. tomato str. DC3000 (NP_791325),
Ralstonia eutropha H16 (YP_841562), and R. metallidurans CH34
(YP_586104).
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